Back to search
Hereditary Transthyretin-mediated (ATTRv) Amyloidosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hereditary Transthyretin-mediated (ATTRv) Amyloidosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hereditary Transthyretin-mediated (ATTRv) Amyloidosis trials you may qualify forThe MaesTTRo study aims to enroll a global cohort of patients with transthyretin (ATTR) amyloidosis to longitudinally observe the natural course of the disease…
This study will be conducted to evaluate the efficacy and safety of a single dose of nexiguran ziclumeran (NTLA-2001) compared to placebo in participants with A…
The purpose of this study is to: * Describe epidemiological and clinical characteristics, natural history and real-world clinical management of ATTR amyloidosi…
ATTRv amyloidosis is a systemic disease with two clinical forms, neurological and cardiological, which are sometimes combined (so-called mixed forms). Patisira…
To evaluate the effectiveness of patisiran in patients with ATTRv amyloidosis with polyneuropathy who have a V122I or T60A mutation.